Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Alexander Staruschenko, PhD, FAHAWelcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy and education relevant to: a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic... Read Dr. Staruschenko's full message

Alexander Staruschenko, PhD, FAHA
Chair, Council on Kidney in Cardiovascular Disease

Hypertension Scientific Sessions 2020

Sept. 10–13, 2020
New Orleans, Louisiana

Learn about Hypertension 2020

Funding Opportunities

AHA research programs are available to basic, clinical and population scientists.



Hypertension is one of 11 AHA journals. It represents the Councils on HBPR and KCVD, in cooperation with the Inter-American Society of Hypertension.

Science NewsView All Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with und...
Self-Measured Blood Pressure Monitoring at Home
06/22/2020 | Hypertension, or high blood pressure, is among the most important risk factors that contribute to the incidence of cardiovascular events ...

Scientific Sessions 2020

Scientific Sessions: Nov. 14–16

Dallas, Texas